Bio-inspired neuroprosthetics: Sending signals the brain can understand

by Ori Schipper,ETH ZurichNeuroscience-driven development of a biomimetic neuroprosthetic device. The successful development of a somatosensory neuroprosthesis is based on three main pillars: (1

Updated on: April 09,2024 0

Bio-inspired neuroprosthetics: Sending signals the brain can understand

by Ori Schipper,ETH ZurichNeuroscience-driven development of a biomimetic neuroprosthetic device. The successful development of a somatosensory neuroprosthesis is based on three main pillars: (1

Updated on:April 09,2024 0

Micro-needle insertion into hippocampus helps brain regeneration in animal model of Alzheimer's disease

by Cell Transplantation Center of Excellence for Aging and Brain RepairResearchers testing the potential positive effects of "micro-injury" by brief insertion of a small needle into the hipp

Updated on: February 28,2024 16

Micro-needle insertion into hippocampus helps brain regeneration in animal model of Alzheimer's disease

by Cell Transplantation Center of Excellence for Aging and Brain RepairResearchers testing the potential positive effects of "micro-injury" by brief insertion of a small needle into the hipp

Updated on:February 28,2024 16

Overlooked tau-RNA interaction may play key role in dementia

by University of WashingtonThis antibody staining experiment shows tau-RNA complexes that have been dyed green. The tau-RNA complex staining strongly resembles neurofibrillary tangles, a hallmark

Updated on: April 29,2024 12

Overlooked tau-RNA interaction may play key role in dementia

by University of WashingtonThis antibody staining experiment shows tau-RNA complexes that have been dyed green. The tau-RNA complex staining strongly resembles neurofibrillary tangles, a hallmark

Updated on:April 29,2024 12

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on: February 28,2024 19

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on:February 28,2024 19

Insurers balk at paying for Biogen's $56,000-a-year Alzheimer's treatment

by John Tozzi, Angelica Lavito and Anushree DaveCredit: CC0 Public DomainU.S. health insurers say they want more proof before paying for Biogen Inc.'s Aduhelm, stalling sales of the costly new Alz

Updated on: April 29,2024 17

Insurers balk at paying for Biogen's $56,000-a-year Alzheimer's treatment

by John Tozzi, Angelica Lavito and Anushree DaveCredit: CC0 Public DomainU.S. health insurers say they want more proof before paying for Biogen Inc.'s Aduhelm, stalling sales of the costly new Alz

Updated on:April 29,2024 17

Opioid analgesics increase the risk of pneumonia among persons with Alzheimer's disease

by University of Eastern FinlandCredit: CC0 Public DomainOpioid analgesics were associated with a 30 percent increase in the risk of pneumonia in persons with Alzheimer's disease, a recent st

Updated on: April 25,2024 15

Opioid analgesics increase the risk of pneumonia among persons with Alzheimer's disease

by University of Eastern FinlandCredit: CC0 Public DomainOpioid analgesics were associated with a 30 percent increase in the risk of pneumonia in persons with Alzheimer's disease, a recent st

Updated on:April 25,2024 15

Australia unprepared to move future Alzheimer's treatment into rapid clinical use

by RAND CorporationCredit: CC0 Public DomainAs in other countries, the Australian health care system has limited capacity to rapidly move a future treatment for Alzheimer's disease from appro

Updated on: April 25,2024 18

Australia unprepared to move future Alzheimer's treatment into rapid clinical use

by RAND CorporationCredit: CC0 Public DomainAs in other countries, the Australian health care system has limited capacity to rapidly move a future treatment for Alzheimer's disease from appro

Updated on:April 25,2024 18

Dementia care in Australia 'fragmented, challenging to navigate and hard to access'

by Medical Journal of Australia (MJA)Credit: CC0 Public DomainAustralia "does not currently meet the human rights of people with dementia to timely and accessible health services of appropriate q

Updated on: April 25,2024 14

Dementia care in Australia 'fragmented, challenging to navigate and hard to access'

by Medical Journal of Australia (MJA)Credit: CC0 Public DomainAustralia "does not currently meet the human rights of people with dementia to timely and accessible health services of appropriate q

Updated on:April 25,2024 14

When does the brain process reward and risk? Neuroscientists test a computational model

by Cynthia Eller,California Institute of TechnologyNeural activity in a region of the brain called the anterior insula could utilize a representation of RePE to then decode RiPE at a later time.

Updated on: March 28,2024 0

When does the brain process reward and risk? Neuroscientists test a computational model

by Cynthia Eller,California Institute of TechnologyNeural activity in a region of the brain called the anterior insula could utilize a representation of RePE to then decode RiPE at a later time.

Updated on:March 28,2024 0

No cure for Alzheimer's disease in my lifetime

by Norman A. Paradis,The ConversationCredit: SAM LIN from PexelsBiogen recently announced that it was abandoning its late stage drug for Alzheimer's,aducanumab, causing investors to&nb

Updated on: April 16,2024 20

No cure for Alzheimer's disease in my lifetime

by Norman A. Paradis,The ConversationCredit: SAM LIN from PexelsBiogen recently announced that it was abandoning its late stage drug for Alzheimer's,aducanumab, causing investors to&nb

Updated on:April 16,2024 20

Common degenerative brain disease may begin to develop already in middle age

byUniversity of HelsinkiImmunohistochemical staining with 5G4 antibody against alpha-synuclein in the Tampere Sudden Death Study cohort. Black arrowheads highlight LBs and gray arrowheads point

Updated on: March 28,2024 0

Common degenerative brain disease may begin to develop already in middle age

byUniversity of HelsinkiImmunohistochemical staining with 5G4 antibody against alpha-synuclein in the Tampere Sudden Death Study cohort. Black arrowheads highlight LBs and gray arrowheads point

Updated on:March 28,2024 0

Faults in the blood-brain barrier implicated in dementia

by Alzheimer's Research UKCalifornia based researchers have found that damage to cells known as pericytes, which surround small blood vessels in the brain, may trigger a chain of events that

Updated on: March 07,2024 18

Faults in the blood-brain barrier implicated in dementia

by Alzheimer's Research UKCalifornia based researchers have found that damage to cells known as pericytes, which surround small blood vessels in the brain, may trigger a chain of events that

Updated on:March 07,2024 18